ALK Chromosome 2

ALK receptor tyrosine kinase
365 variants 365 Health Risk

Upload your DNA to see your personal genotypes for variants in ALK.

What This Gene Does
This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]
Gene Info
Gene Group
"Receptor tyrosine kinases|CD molecules"
Locus Type
gene with protein product
Location
2p23.2-p23.1
Ensembl
ENSG00000171094
Associated Conditions (14)
Neuroblastoma
susceptibility to
3
Hereditary cancer-predisposing syndrome
Ovarian cancer
ALK-related disorder
Ovarian serous cystadenocarcinoma
Familial isolated pituitary adenoma
Diffuse midline glioma
H3 K27-altered
Malignant tumor of urinary bladder
Lung cancer
Rhabdomyosarcoma
Neoplasm
Key Variants
All Variants (365)
RSID Category Clinical Significance Conditions
RS1010580453 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1019065457 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1046338903 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1060500214 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1060500225 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1060500231 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS113303272 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS113994090 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS113994091 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1165737526 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1165866210 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1172956542 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1189878579 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1208409389 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1226555490 Health Risk Conflicting classifications of pathogenicity Hereditary cancer-predisposing syndrome, Neuroblastoma, susceptibility to
RS1236590521 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1237752481 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1244823020 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1264537420 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1265006535 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1267142388 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1268649558 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1272214012 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1275855734 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1278070199 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1280277994 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1286011012 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1296992304 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1302907379 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1316424431 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1326321652 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1333697872 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1337002578 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1338200771 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1345881154 Health Risk Conflicting classifications of pathogenicity Hereditary cancer-predisposing syndrome, Neuroblastoma, susceptibility to
RS1365620880 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1371180882 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1374146241 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS138178848 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS138589984 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS138686378 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1388736375 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1400037080 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS140733978 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS140928266 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS141010693 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS141093002 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS141242925 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS142120301 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
RS1430369916 Health Risk Conflicting classifications of pathogenicity Neuroblastoma, susceptibility to, 3
1 2 3 4 ... 8 Next »
Sign Up to Analyze Your DNA Log In